Distribution of blaOXA-carrying imipenem-resistant Acinetobacter spp. in 3 hospitals in Taiwan

Diagnostic Microbiology and Infectious Disease

Volumn 66, Issue 2, 2010, Pages 195-199

  Kuo, Han Yueh ^a   Yang, Chih Man ^a   Lin, Ming Feng ^b   Cheng, Wen Lin ^c   Tien, Ni ^d   Liou, Ming Li ^c  

^a Hsin Chu General Hospital   (Taiwan)

^b Chutung Hospital   (Taiwan)

^c YUANPEI UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Acinetobacter spp.; blaOXA 23 gene; blaOXA 24 gene; blaOXA 51 gene; Pulsed field gel electrophoresis

Indexed keywords

AMIKACIN; BLAOXA 23 PROTEIN; BLAOXA 24 PROTEIN; BLAOXA 51 PROTEIN; BLAOXA PROTEIN; CARBAPENEMASE; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TETRACYCLINE; UNCLASSIFIED DRUG;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; CONTROLLED STUDY; GENOTYPE; MOLECULAR EPIDEMIOLOGY; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; TAIWAN; UNIVERSITY HOSPITAL;

ACINETOBACTER; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIAL TYPING TECHNIQUES; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CLUSTER ANALYSIS; DNA FINGERPRINTING; ELECTROPHORESIS, GEL, PULSED-FIELD; GENOTYPE; HOSPITALS, UNIVERSITY; HUMANS; IMIPENEM; MOLECULAR EPIDEMIOLOGY; TAIWAN;

EID: 73749085776     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2009.09.013     Document Type: Article

References (28)

1. Bergogne-Bérézin E., and Towner K.J. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin. Microbiol. Rev. 9 (1996) 148-165
2. Bou G., Cerveró G., et al. Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii Strain with a carbapenem-Hydrolyzing enzyme: high-level carbapenem resistance in A. baumannii is not due solely to the presence of β-lactamases. J. Clin. Microbiol. 38 (2000) 3299-3305
3. Chang H.C., Wei Y.F., et al. Species-level identification of isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex by sequence analysis of the 16S-23S rRNA gene spacer region. J. Clin. Microbiol. 43 (2005) 1632-1639
4. Chen T.L., Siu L.K., et al. Comparison of one-tube multiplex PCR, automated ribotyping and intergenic spacer (ITS) sequencing for rapid identification of Acinetobacter baumannii. Clin. Microbial. Infect. 13 (2007) 801-806
5. Chen C.M., Liu P.Y., et al. Investigation of carbapenem-resistant Acinetobacter baumannii isolates in a district hospital in Taiwan. Diag. Microbiol. Infect. Dis. 63 (2009) 394-397
6. Clinical and Laboratory Standards Institute (CLSI). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-seventh edition, M7-A6 (2003), CLSI, Wayne, PA
7. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial disk susceptibility tests: ninth information supplement (M2-A9) (2006), CLSI, Wayne, PA
8. Coelho J.M., Turton J.F., et al. Occurrence of carbapenem-resistant Acinetobacter baumannii clones at multiple hospitals in London and Southeast England. J. Clin. Microbiol. 44 (2006) 3623-3627
9. Jean S.S., Hsueh P.R., et al. Nationwide surveillance of antimicrobial resistance among non-fermentative Gram-negative bacteria in intensive care units in Taiwan, SMART programme data 2005. Int. J. Antimicrob. Agents 33 (2009) 266-271
10. Lolans K., Rice T.W., et al. Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40. Antimicrob. Agents Chemother. 50 (2006) 2941-2945
11. Lu P.L., Huang L.Y., et al. How carbapenem-resistant Acinetobacter spp. established in a newly constructed hospital. Int. J. Antimicrob. Agents 31 (2008) 463-466
12. Maltezou H.C. Metallo-beta-lactamases in Gram-negative bacteria: introducing the era of pan-resistance?. Int. J. Antimicrob. Agents 33 (2009) 405.e1-405.e7
13. Mendes R.E., Bell J.M., et al. Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Programs. J. Antimicrob. Chemother. 63 (2009) 55-59
14. Navon-Venezia S., Ben-Ami R., et al. Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting. Curr. Opin. Infect. Dis. 18 (2005) 306-313
15. Perez F., Hujer A.M., et al. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 51 (2007) 3471-3484
16. Poirel L., and Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin. Microbiol. Infect. 12 (2006) 826-836
17. Qi C., Malczynski M., et al. Characterization of genetic diversity of carbapenem-resistant Acinetobacter baumannii clinical strains collected from 2004 to 2007. J. Clin. Microbiol. 46 (2008) 1106-1109
18. Seifert H., Dolzani L., et al. Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii. J. Clin. Microbiol. 43 (2005) 4328-4335
19. Stoeva T., Higgins P.G., et al. Clonal spread of carbapenem-resistant OXA-23-positive Acinetobacter baumannii in a Bulgarian university hospital. Clin. Microbiol. Infect. 14 (2008) 723-727
20. Tenover F.C., Arbeit R.D., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33 (1995) 2233-2239
21. Tsakris A., Ikonomidis A., et al. Clusters of imipenem-resistant Acinetobacter baumannii clones producing different carbapenemases in an intensive care unit. Clin. Microbiol. Infect. 14 (2008) 588-594
22. Turton J.F., Ward M.E., et al. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol. Lett. 258 (2006) 72-77
23. Villegas M.V., Kattan J.N., et al. Dissemination of Acinetobacter baumannii clones with OXA-23 carbapenemase in Colombian hospitals. Antimicrob. Agents Chemother. 51 (2007) 2001-2004
24. Walsh TR. Clinically significant carbapenemases: an update. Curr. Opin. Infect. Dis. 21 (2008) 367-371
25. Walther-Rasmussen J., and Høiby N. OXA-type carbapenemases. J. Antimicrob. Chemother. 57 (2006) 373-383
26. Wang H., Guo P., et al. Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals. Antimicrob. Agents Chemother. 51 (2007) 4022-4028
27. Woodford N., Ellington M.J., et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int. J. Antimicrob. Agents 27 (2006) 351-353
28. Zarrilli R., Crispino M., et al. Molecular epidemiology of sequential outbreaks of Acinetobacter baumannii in an intensive care unit shows the emergence of carbapenem resistance. J. Clin. Microbiol. 42 (2004) 946-953